In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

The impact of multidisciplinary team approach with critical care specialist and cardiologist co-management style on the clinical outcomes of cardiac intensive care unit patients.

Session Acute intensive cardiovascular care

Speaker William Weintraub

Event : ESC Congress 2015

  • Topic : coronary artery disease, acute coronary syndromes, acute cardiac care
  • Sub-topic : Acute Cardiac Care – CCU, Intensive, and Critical Cardiovascular Care
  • Session type : Rapid Fire Abstracts

Authors : Z Fanari (Newark,US), A Barekatain (Newark,US), R Kerzner (Newark,US), S Hammami (Newark,US), WS Weintraub (Newark,US), V Maheshwari (Newark,US)

Z. Fanari1 , A. Barekatain1 , R. Kerzner1 , S. Hammami1 , W.S. Weintraub1 , V. Maheshwari2 , 1Christiana Hospital, Section of Cardiology - Newark - United States of America , 2Christiana Hospital, Section of Pulmonary & Critical Care Medicine. - Newark - United States of America ,

European Heart Journal ( 2015 ) 36 ( Abstract Supplement ), 884

Background: There is increased complexity of patients' care in intensive care units that has motivated the involvement of critical care trained physicians as a part of multidisciplinary approach in medical, surgical and neurological ICUs. Multidisciplinary care has been less common in cardiac care units (CCUs).

Purpose: To determine whether a multidisciplinary team approach with a critical care specialists and cardiologist co-management style will impact the clinical outcomes of CCU patients.

Methods: A formal protocol was implemented starting July 2012 in a hospital whereby a medical intensivist integrated with the multidisciplinary team. This team included a cardiologist, a medical intensivist, a cardiology fellow, internal medicine residents and interns, ICU nurses, ICU pharmacist and respiratory therapists. Responsibilities were delineated in a fashion such that the intensivist primarily managed non-cardiac issues, deferring primary cardiologic issues to the cardiologist. Patients were divided to low, intermediate and high risk depending on their mortality risk based on APACHE III score.

Results: 2475 patients were included with 916 patients admitted in the 12 months before and 1516 admitted in the 12 months after intervention. Patients admitted after the intervention had a higher morbidity rate expressed by a higher mean APACHE III (56.26 vs. 53.87; P<0.001), SAPS II (44.49 vs. 41.49; P<0.001). Results showed that the implementation of the intensivist multidisciplinary team model was associated with a significant decrease in both CCU Mortality (3.52 vs. 5.85%; odds ratio OR=0.59; 95% CI (0.39–0.88); P=0.01) and in-hospital mortality (4.37 vs. 11.13%; OR=0.37; 95% CI (0.26–0.52); P<0.0001). Furthermore; there was also a significant reduction in both CICU length of stay (LOS) (2.46±3 vs. 2.84±3 days; P=0.006), hospital LOS (7.03±4.5 vs. 7.53±4.5 days; P=0.006) and days on ventilation for intubated patients (1.96±1 vs. 4.32±2.8; P=0.0001). The reduction in mortality and LOS was noticed mainly in intermediate and high risk patients, while the reduction in days on ventilation was seen in all subgroups.

Conclusion: The implementation of a multidisciplinary team approach where an intensivist and cardiologist co-manage the critical care of CCU patients is associated with reduced ICU and in-hospital mortality, ICU and in-hospital LOS and duration of mechanical ventilation

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are